Cytostatic activity of chlamydocin, a rapidly inactivated cyclic tetrapeptide.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D002452:Cell Count; D002455:Cell Division / Q000187:drug effects; D004988:Ethers, Cyclic / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D006358:Hot Temperature; D066298:In Vitro Techniques; D007269:Injections, Intra-Arterial; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007928:Lethal Dose 50; D007939:Leukemia L1210 / Q000188:drug therapy; D012515:Mast-Cell Sarcoma / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D010456:Peptides, Cyclic / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D051381:Rats
D000903:Antibiotics, Antineoplastic; D004988:Ethers, Cyclic; D010456:Peptides, Cyclic